✦ LIBER ✦

Inhibition of Invasion and Metastasis by Glypican-3 in a Syngeneic Breast Cancer Model

✍ Scribed by M.G. Peters; E. Farías; L. Colombo; J. Filmus; L. Puricelli; E. Bal de Kier Joffé

Book ID: 111543088
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 380 KB
Volume: 80
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1024549729256

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumour invasion and metastasis initiated

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

✍ Ma, Li; Teruya-Feldstein, Julie; Weinberg, Robert A. 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 974 KB

Tumour invasion and metastasis initiated

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

✍ Ma, Li; Teruya-Feldstein, Julie; Weinberg, Robert A. 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Antagonism of CXCR3 Inhibits Lung Metast

Antagonism of CXCR3 Inhibits Lung Metastasis in a Murine Model of Metastatic Breast Cancer

✍ Walser, T. C. 📂 Article 📅 2006 🏛 American Association for Cancer Research 🌐 English ⚖ 492 KB

Inhibition of breast cancer derived cell

Inhibition of breast cancer derived cell invasion by Suramin in vitro

✍ A. de Cupis; R.E. Favoni; P. Pirani; S. Toma; S. Parodi; A. Albini 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 187 KB

0105 Is there a promotion of metastasis

0105 Is there a promotion of metastasis by autologeous breast reconstruction in patients with invasive breast cancer?

✍ A. Smeets; K.K. Van Calster; H. Wildiers; J.J.P. Lobelle; M.M. Vandevoort; P. Ne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Inhibition of cell proliferation, invasi

Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model

✍ Bal L. Lokeshwar; Marie G. Selzer; Bao-Qian Zhu; Norman L. Block; Lorne M. Golub 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 460 KB

## Abstract Antibiotic forms of tetracycline exhibit antitumor activity in some tumor models. However, their low __in vivo__ efficacy and associated morbidity limit their long‐term application in cancer therapy. This report appraises the efficacy of doxycycline (DC) and non‐antimicrobial, chemicall